Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Pulmonary Edema D011654 23 associated lipids
Coronary Disease D003327 70 associated lipids
Intestinal Obstruction D007415 6 associated lipids
Pancreatitis D010195 10 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Hypersensitivity D006967 22 associated lipids
Osteosarcoma D012516 50 associated lipids
Rhinitis D012220 10 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Asphyxia Neonatorum D001238 4 associated lipids
Melanoma D008545 69 associated lipids
Asthma D001249 52 associated lipids
Weight Gain D015430 101 associated lipids
Brain Diseases D001927 27 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Glioma D005910 112 associated lipids
Staphylococcal Infections D013203 15 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Borgquist JD et al. Adhesion to extracellular matrix proteins modulates bovine neutrophil responses to inflammatory mediators. 2002 J. Leukoc. Biol. pmid:11994500
Kalkanci A et al. The role of tumour necrosis factor-alpha (TNF-alpha) and platelet-activating factor (PAF) interaction on murine candidosis. 2002 Mycoses pmid:12000505
McManus LM and Pinckard RN PAF, a putative mediator of oral inflammation. 2000 Crit. Rev. Oral Biol. Med. pmid:12002818
Barbuti A et al. Block of the background K(+) channel TASK-1 contributes to arrhythmogenic effects of platelet-activating factor. 2002 Am. J. Physiol. Heart Circ. Physiol. pmid:12003807
Zimmerman GA et al. The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis. 2002 Crit. Care Med. pmid:12004251
Benito E and Bosch MA Role of platelet-activating factor in phosphatidylcholine secretion in primary cultures of rat type II pneumocytes. 2002 Prostaglandins Other Lipid Mediat. pmid:12013527
Zhang J et al. Effect of buyang huanwu decoction on platelet activating factor content in arterial blood pre- and post-arterial thrombosis in rats. 2001 J Tradit Chin Med pmid:12014136
Ottino P et al. Platelet-activating factor induces the gene expression of TIMP-1, -2, and PAI-1: imbalance between the gene expression of MMP-9 and TIMP-1 and -2. 2002 Exp. Eye Res. pmid:12014920
Michalis LK et al. Platelet hyperaggregability to platelet activating factor (PAF) in non-ST elevation acute coronary syndromes. 2002 Curr Med Res Opin pmid:12017208
Iatrou C et al. Is platelet-activating factor produced during hemodialysis with AN-69 polyacrylonitrile membrane? 2002 Nephron pmid:12021524
Sakai H et al. E3040 sulphate, a novel thromboxane synthase inhibitor, blocks the Cl- secretion induced by platelet-activating factor in isolated rat colon. 2002 Br. J. Pharmacol. pmid:12023941
Acuña AA et al. Fluticasone propionate attenuates platelet-activating factor-induced gas exchange defects in mild asthma. 2002 Eur. Respir. J. pmid:12030727
Honda Z et al. Platelet-activating factor receptor. 2002 J. Biochem. pmid:12038971
Lloberas N et al. Postischemic renal oxidative stress induces inflammatory response through PAF and oxidized phospholipids. Prevention by antioxidant treatment. 2002 FASEB J. pmid:12039876
Zhou ZG and Chen YD Influencing factors of pancreatic microcirculatory impairment in acute panceatitis. 2002 World J. Gastroenterol. pmid:12046059
Kato T et al. Mitochondrial calcium response in human transformed lymphoblastoid cells. 2002 Life Sci. pmid:12052442
Silva-Neto MA et al. Platelet-activating factor (PAF) activates casein kinase 2 in the protozoan parasite Herpetomonas muscarum muscarum. 2002 Biochem. Biophys. Res. Commun. pmid:12054663
Kingston JK et al. Effects of formaldehyde fixation on equine platelets using flow cytometric methods to evaluate markers of platelet activation. 2002 Am. J. Vet. Res. pmid:12061530
Steel HC et al. Platelet-activating factor and lyso-PAF possess direct antimicrobial properties in vitro. 2002 APMIS pmid:12064871
Levine AS et al. A review of the effect of platelet-activating factor on male reproduction and sperm function. 2002 Jul-Aug J. Androl. pmid:12065449
Yoshikawa M et al. Effect of extracellular matrix proteins on platelet-activating factor-induced eosinophil chemotaxis. 2002 Int. Arch. Allergy Immunol. pmid:12065903
Nakamura T et al. Relationship between the platelet activating factor acetylhydrolase gene and intractability of ulcerative colitis. 2002 Dis. Colon Rectum pmid:12068200
Tsuyuki K et al. Possible participation of intracellular platelet-activating factor in NF-kappaB activation in rat peritoneal macrophages. 2002 Biochim. Biophys. Acta pmid:12069846
Jaracz S et al. Ginkgolides: selective acetylations, translactonization, and biological evaluation. 2002 J. Org. Chem. pmid:12076171
Downing SJ et al. Effect of inflammatory mediators on the physiology of the human Fallopian tube. 2002 Hum Fertil (Camb) pmid:12082208
Klabunde RE and Anderson DE Role of nitric oxide and reactive oxygen species in platelet-activating factor-induced microvascular leakage. 2002 May-Jun J. Vasc. Res. pmid:12097822
Mohr PJ and Halcomb RL Convergent enantioselective synthesis of the tricyclic core of phomactin A. 2002 Org. Lett. pmid:12098260
Yoshida H et al. Platelet-activating factor enhances the expression of vascular endothelial growth factor in normal human astrocytes. 2002 Brain Res. pmid:12106666
Unno N et al. Single nucleotide polymorphism (G994-->T) in the plasma platelet-activating factor-acetylhydrolase gene is associated with graft patency of femoropopliteal bypass. 2002 Surgery pmid:12110797
Parker MA et al. Platelet-activating factor induces permeability transition and cytochrome c release in isolated brain mitochondria. 2002 J. Neurosci. Res. pmid:12111814
Chang HW et al. Platelet-activating factor acetylhydrolase activity in cerebrospinal fluid of children with acute systemic or neurological illness. 2002 Ann. Neurol. pmid:12112082
Talvani A et al. Leukotriene B(4) induces nitric oxide synthesis in Trypanosoma cruzi-infected murine macrophages and mediates resistance to infection. 2002 Infect. Immun. pmid:12117933
Sun Z et al. Effective treatment of gut barrier dysfunction using an antioxidant, a PAF inhibitor, and monoclonal antibodies against the adhesion molecule PECAM-1. 2002 J. Surg. Res. pmid:12121711
Mayer K et al. Omega-3 fatty acids suppress monocyte adhesion to human endothelial cells: role of endothelial PAF generation. 2002 Am. J. Physiol. Heart Circ. Physiol. pmid:12124231
Giorgi G et al. Mass spectrometric characterization of substituted 2-thiazolin-4-one derivatives. 2002 J Mass Spectrom pmid:12125004
Benveniste J et al. [Semi-synthesis and proposed structure of platelet-activating factor (P.A.F.): PAF-acether an alkyl ether analog of lysophosphatidylcholine]. 1979 C. R. Acad. Sci., D, Sci. Nat. pmid:121258
Kulikov VI and Muzya GI Influence of platelet-activating factor, its cell analogs, and antagonist on the production of superoxide radicals by blood leukocytes of healthy and hypercholesterolemic individuals. 2002 Biochemistry Mosc. pmid:12126473
Leusch A et al. Altered drug disposition of the platelet activating factor antagonist apafant in mdr1a knockout mice. 2002 Eur J Pharm Sci pmid:12128165
Megens AA et al. Pharmacological profile of (2R-trans)-4-[1-[3,5-bis(trifluoromethyl)benzoyl]-2-(phenylmethyl)-4-piperidinyl]-N-(2,6-dimethylphenyl)-1-acetamide (S)-Hydroxybutanedioate (R116301), an orally and centrally active neurokinin-1 receptor antagonist. 2002 J. Pharmacol. Exp. Ther. pmid:12130734
Teather LA et al. Platelet-activating factor increases prostaglandin E(2) release from astrocyte-enriched cortical cell cultures. 2002 Brain Res. pmid:12133598
Fujiu T et al. Cellular adhesion is required for effector functions of human eosinophils via G-protein coupled receptors. 2002 Ann. Allergy Asthma Immunol. pmid:12141728
Bazan NG et al. What synaptic lipid signaling tells us about seizure-induced damage and epileptogenesis. 2002 Prog. Brain Res. pmid:12143339
McLennan SV et al. Effects of mesangium glycation on matrix metalloproteinase activities: possible role in diabetic nephropathy. 2002 Diabetes pmid:12145178
Claud EC et al. Platelet-activating factor regulates chloride transport in colonic epithelial cell monolayers. 2002 Pediatr. Res. pmid:12149490
De Plaen IG et al. Endotoxin, but not platelet-activating factor, activates nuclear factor-kappaB and increases IkappaBalpha and IkappaBbeta turnover in enterocytes. 2002 Immunology pmid:12153521
Fonteh AN Differential effects of arachidonoyl trifluoromethyl ketone on arachidonic acid release and lipid mediator biosynthesis by human neutrophils. Evidence for different arachidonate pools. 2002 Eur. J. Biochem. pmid:12153573
Li L et al. Antiplatelet aggregation activity of diterpene alkaloids from Spiraea japonica. 2002 Eur. J. Pharmacol. pmid:12163102
Ryan KL et al. Platelet-activating factor does not mediate circulatory failure induced by 35-GHz microwave heating. 2002 Methods Find Exp Clin Pharmacol pmid:12168504
Takizawa T et al. Inhibition of protein kinases A and C demonstrates dual modes of response in human eosinophils stimulated with platelet-activating factor. 2002 J. Allergy Clin. Immunol. pmid:12170264
Sakai H et al. Nitric oxide-induced Cl- secretion in isolated rat colon is mediated by the release of thromboxane A2. 2002 J. Physiol. (Lond.) pmid:12181297
Podolak-Dawidziak M [Role of white cells and neoplastic cells in haemostasis]. 2002 Pol. Arch. Med. Wewn. pmid:12189915
Strømgaard K et al. Ginkgolide derivatives for photolabeling studies: preparation and pharmacological evaluation. 2002 J. Med. Chem. pmid:12190325
Wong RK et al. Augmentation of the neutrophil respiratory burst through the action of advanced glycation end products: a potential contributor to vascular oxidant stress. 2002 Diabetes pmid:12196480
Goldring WP and Pattenden G A total synthesis of phomactin A. 2002 Chem. Commun. (Camb.) pmid:12196974
Ewer AK Role of platelet-activating factor in the pathophysiology of necrotizing enterocolitis. 2002 Acta Paediatr Suppl pmid:12200892
Göggel R et al. Platelet-activating factor-induced pulmonary edema is partly mediated by prostaglandin E(2), E-prostanoid 3-receptors, and potassium channels. 2002 Am. J. Respir. Crit. Care Med. pmid:12204861
Bazan H and Ottino P The role of platelet-activating factor in the corneal response to injury. 2002 Prog Retin Eye Res pmid:12207945
Bussolati B et al. Expression of CD154 on renal cell carcinomas and effect on cell proliferation, motility and platelet-activating factor synthesis. 2002 Int. J. Cancer pmid:12209602
Cadwallader KA et al. Regulation of phosphatidylinositol 3-kinase activity and phosphatidylinositol 3,4,5-trisphosphate accumulation by neutrophil priming agents. 2002 J. Immunol. pmid:12218155
Cuschieri J et al. Platelet-activating factor priming of inflammatory cell activity requires cellular adherence. 2002 Surgery pmid:12219006
Colwell JA et al. Platelet adhesion and aggregation in diabetes mellitus. 1979 Metab. Clin. Exp. pmid:122293
Bussolati B et al. Nitric oxide/platelet activating factor cross-talk in mesangial cells modulates the interaction with leukocytes. 2002 Kidney Int. pmid:12234302
Weyrich AS et al. Platelets, endothelial cells, inflammatory chemokines, and restenosis: complex signaling in the vascular play book. 2002 Circulation pmid:12234942
Han SJ et al. Molecular mechanisms for lipopolysaccharide-induced biphasic activation of nuclear factor-kappa B (NF-kappa B). 2002 J. Biol. Chem. pmid:12235132
Akai T et al. Modulation of tissue-type plasminogen activator expression by platelet activating factor in human glioma cells. 2002 J. Neurooncol. pmid:12241114
Donnard M et al. Membrane and intracellular platelet-activating factor receptor expression in leukemic blasts of patients with acute myeloid and lymphoid leukemia. 2002 Stem Cells pmid:12351810
Leung SW et al. Platelet-activating factor enhanced the pressor response of endothelin-1. 2002 J. Cardiovasc. Pharmacol. pmid:12352314
Brewer C et al. Platelet activating factor-induced apoptosis is inhibited by ectopic expression of the platelet activating factor G-protein coupled receptor. 2002 J. Neurochem. pmid:12354298
Marin V et al. Chemotactic agents induce IL-6Ralpha shedding from polymorphonuclear cells: involvement of a metalloproteinase of the TNF-alpha-converting enzyme (TACE) type. 2002 Eur. J. Immunol. pmid:12355450
Beauchamp MH et al. Platelet-activating factor in vasoobliteration of oxygen-induced retinopathy. 2002 Invest. Ophthalmol. Vis. Sci. pmid:12356842
Downing SJ et al. Effect of platelet-activating factor on the electrophysiology of the human Fallopian tube: early mediation of embryo-maternal dialogue? 2002 Reproduction pmid:12361471
Teather LA et al. Platelet-activating factor antagonists decrease the inflammatory nociceptive response in rats. 2002 Psychopharmacology (Berl.) pmid:12373444
Baker PR et al. Regulation of platelet-activating factor synthesis in human neutrophils by MAP kinases. 2002 Biochim. Biophys. Acta pmid:12379481
Michibayashi T Platelet aggregating response to platelet activating factor participates in activation of the 12-lipoxygenase pathway in platelets from rabbits. 2002 Int Angiol pmid:12384648
Shigematsu S et al. Bradykinin-induced proinflammatory signaling mechanisms. 2002 Am. J. Physiol. Heart Circ. Physiol. pmid:12388246
Maul H et al. Local application of platelet-activating factor induces cervical ripening accompanied by infiltration of polymorphonuclear leukocytes in rats. 2002 Am. J. Obstet. Gynecol. pmid:12388958
Murohisa G et al. Involvement of platelet-activating factor in hepatic apoptosis and necrosis in chronic ethanol-fed rats given endotoxin. 2002 Liver pmid:12390475
Kato M et al. Platelet-activating factor activates two distinct effector pathways in human eosinophils. 2002 J. Immunol. pmid:12391244
Ueno H et al. Coagulation/fibrinolysis abnormality and vascular endothelial damage in the pathogenesis of thrombocytopenic multiple organ failure. 2002 Crit. Care Med. pmid:12394951
Sibelius U et al. Distinct pathways of lipopolysaccharide priming of human neutrophil respiratory burst: role of lipid mediator synthesis and sensitivity to interleukin-10. 2002 Crit. Care Med. pmid:12394960
Sakamoto H et al. Overexpression of phospholipid hydroperoxide glutathione peroxidase modulates acetyl-CoA, 1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine acetyltransferase activity. 2002 J. Biol. Chem. pmid:12397078
Ibe BO et al. Metabolism of platelet activating factor by intrapulmonary vascular smooth muscle cells. Effect of oxygen on phospholipase A2 protein expression and activities of acetyl-CoA acetyltransferase and cholinephosphotransferase. 2002 Mol. Genet. Metab. pmid:12409272
Childs EW et al. In vivo visualization of reactive oxidants and leukocyte-endothelial adherence following hemorrhagic shock. 2002 Shock pmid:12412620
Farbiszewski R et al. [The role of platelet activating factor (PAF) in physiology and pathology of the central nervous system]. 2002 Jul-Aug Neurol. Neurochir. Pol. pmid:12418143
Eikelboom JW et al. Clopidogrel does not suppress blood markers of coagulation activation in aspirin-treated patients with non-ST-elevation acute coronary syndromes. 2002 Eur. Heart J. pmid:12419297
Tanaka S and Koike T Selective inflammatory stimulations enhance release of microglial response factor (MRF)-1 from cultured microglia. 2002 Glia pmid:12420315
Maniscalco M et al. Nitric oxide attenuates platelet-activating factor induced nasal airway plasma extravasation in healthy subjects. 2002 Eur. J. Clin. Invest. pmid:12423328
Hsueh W et al. Neonatal necrotizing enterocolitis: clinical considerations and pathogenetic concepts. 2003 Jan-Feb Pediatr. Dev. Pathol. pmid:12424605
Dun Y et al. Activated polymorphonuclear leukocytes induce cardiomyocyte apoptosis and the protective effects of carvedilol. 2002 Methods Find Exp Clin Pharmacol pmid:12428428
Fallani A et al. Synthesis of platelet-activating factor (PAF) in transformed cell lines of a different origin. 2002 Prostaglandins Other Lipid Mediat. pmid:12428690
Gélinas DS et al. Immediate and delayed VEGF-mediated NO synthesis in endothelial cells: role of PI3K, PKC and PLC pathways. 2002 Br. J. Pharmacol. pmid:12429574
Mahmoud FF et al. In vitro effects of ginkgolide B combined with cyclosporin A on T-lymphocyte activation and IL-5 expression in peripheral blood mononuclear cells from asthmatic subjects. 2002 Transplant. Proc. pmid:12431672
Arai H Platelet-activating factor acetylhydrolase. 2002 Prostaglandins Other Lipid Mediat. pmid:12432911
Ishii S et al. Platelet-activating factor receptor. 2002 Prostaglandins Other Lipid Mediat. pmid:12432946
Lee YM et al. Platelet-activating factor induces lung inflammation and leak in rats: hydrogen peroxide production along neutrophil-lung endothelial cell interfaces. 2002 J. Lab. Clin. Med. pmid:12434132
Abu-Zidan FM and Windsor JA Lexipafant and acute pancreatitis: a critical appraisal of the clinical trials. 2002 Eur J Surg pmid:12440758
Pawliczak R et al. Oxidative stress induces arachidonate release from human lung cells through the epithelial growth factor receptor pathway. 2002 Am. J. Respir. Cell Mol. Biol. pmid:12444032
MacKinnon AC et al. Sphingosine kinase: a point of convergence in the action of diverse neutrophil priming agents. 2002 J. Immunol. pmid:12444147
Marrache AM et al. Proinflammatory gene induction by platelet-activating factor mediated via its cognate nuclear receptor. 2002 J. Immunol. pmid:12444157
Pacheco P et al. Lipopolysaccharide-induced leukocyte lipid body formation in vivo: innate immunity elicited intracellular Loci involved in eicosanoid metabolism. 2002 J. Immunol. pmid:12444160